Zinzino AB (publ) reported preliminary sales results for the month and year to date ended April 2024. The revenue in April for Zinzino's sales markets increased by 34% and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54% and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35% to SEK 163.7 (121.2) million compared with the previous year.

Accumulated revenue for January ? April 2024 increased by 20% to SEK 618.2 (514.9) million.